AlphAIalphai — Financial news for AI agents
Stock TitanAPR 302 min read$SSSS

Director’s trust sells 10,669 SuRo Capital (SSSS) shares at $12.90

A trust associated with Ronald M. Lott, a director of SuRo Capital Corp. (SSSS), has sold 10,669 shares of common stock at a weighted-average price of $12.90 per share. Following this transaction, Lott directly holds 7,812 shares, including restricted shares that are set to vest on May 28, 2026, or the closest annual meeting. This insider sale is categorized with a moderate impact and negative sentiment.

Original reporting
Stock Titan
Published Apr 30, 2026, 3:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 30, 2026, 4:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Director’s trust sells 10,669 SuRo Capital (SSSS) shares at $12.90 — source image
Source · Stock Titan
Decision brief

The 30-second read

$SSSSBearishMed
01

Why it matters

While the sale is noteworthy, it does not conclusively indicate a negative outlook; further context is needed.

02

Market read

Insider trading activity is a factor to monitor but should be considered alongside other fundamental and technical indicators.

03

What to watch

The continued holdings and upcoming vesting could mean the insider maintains confidence in the company's long-term prospects.

Timing: Immediate, as the transaction occurred on 2026-04-30.

Background

Insider trading activity can signal management's confidence or concern; in this case, a director sold shares but still holds a significant position.

Company-level read

Ticker impact

$SSSSBearishMedium confidence
Context

Insider trading activity involving a director of SuRo Capital Corp.

Expected impact

Potential short-term downward pressure on SSSS stock due to insider selling, but overall impact remains moderate given the insider's continued holdings.

Evidence & confidence

The sale indicates some level of insider caution; however, the director's ongoing holdings and vesting schedule suggest limited immediate negative impact.

Market effects

Sector

Limited sector impact; insider sales are company-specific and do not necessarily reflect sector-wide trends.

Regional

Minimal regional impact; focus remains on company-specific activity.

Global

Negligible; insider trading activity of a single company has limited global market influence.

Counterpoint

What could challenge this read

The insider sale may be routine portfolio rebalancing and not indicative of negative outlook.

Key entities

  • Person
    Ronald M. Lott

    Director of SuRo Capital Corp.

  • Company
    SuRo Capital Corp.

    A publicly traded investment company.

Read at source← All news

Related articles

AUG 11
$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

insidermonkey.com6 min
AUG 11
$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

yahoo.com6 min
AUG 11
$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.

oilandgas360.com4 min
AUG 10
$NVDAMed

Nvidia partners with lenders to finance AI infrastructure

Nvidia said it will partner with a lender consortium including Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to create financing vehicles totaling more than $500 billion for AI infrastructure. Nvidia links the plan to customer access to compute and its DSX datacenter design. The company has recently backstopped customer lending and used its balance sheet for deals such as with OpenAI. Nvidia shares fell on the news.

yahoo.com4 min
AUG 10
$ONDSMed

Dzyne gets $6M Air Force Contract

Dzyne Technologies, an Irvine-based unit of Ondas Technologies, received a $6 million U.S. Air Force contract to develop the Long-Range Grasshopper aerial delivery system, according to Ondas. The system targets extended-range logistics in contested and austere environments. Ondas said the work will be integrated into its Ondas Sentinel platform.

ocbj.com2 min